EXCLUSIVE: BioBridge Completes PIUMS Project; Partner AstraZeneca Collects First Unit | GenomeWeb

NEW YORK, Sept. 6 – BioBridge Computing has finished developing its PIUMS protein identification software and has delivered the first unit to its research partner AstraZeneca, GenomeWeb has learned.

PIUMS—or Protein Identification Using Mass Spectrometry—is a fully automated software that includes Pepex, BioBridge’s peak extraction software. The two companies have been developing the software since they first struck a deal in July to develop the product.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.